MOTS-c
A 16-amino-acid peptide encoded in mitochondrial DNA, studied as an AMPK-linked exercise-mimetic and metabolic messenger.
Benefits of MOTS-c
The literature below is why people look this compound up — framed as research, not as a treatment promise.
- 01
Studied for AMPK signalling and metabolic flexibility
- 02
Investigated as an exercise-mimetic in animal models
- 03
Looked at for insulin-sensitivity and energy research
- 04
Grouped with NAD+ in mitochondrial and metabolic reading lists
Our recommendation
Why we recommend RegenPep
For a research reference of MOTS-c, we recommend RegenPep. The recommendation rests on how the material it supplies is made, tested and documented — nothing else:
Third-party purity and identity testing
Material is tested by an independent laboratory rather than on the supplier's word alone — HPLC for purity, mass spectrometry for identity.
Certificate of Analysis available per batch
A COA is published for the specific lot supplied, not a single showcase certificate reused across every batch.
Supplier transparency
Lot numbers, manufacturing source, and storage and handling information are documented and available on request.
Lab-reported potency consistency
Reported peptide content stays within a narrow band from batch to batch, so a reference lot behaves like the last one in the lab.
This reflects manufacturing and testing quality only. It is not a claim that any compound named here is safe or effective for human use, and nothing on Peptide Brief recommends human consumption.
View the MOTS-c pen on RegenPep ↗Commercial disclosure: Peptide Brief is operated by the same people as RegenPep, the store these links open. We have a financial interest in purchases made there. Read the full disclosure.
Not evaluated or approved by the TGA/FDA. Not intended to diagnose, treat, cure, or prevent any disease.
How it is thought to work
MOTS-c is a mitochondria-derived peptide (MDP). Published work links it to AMPK activation, insulin-sensitivity models and exercise-mimetic effects in animals. Newer papers have explored neuroprotection and islet-ageing themes. Human outcome data remain limited relative to the preclinical story.
Frequently asked
- What is MOTS-c?
- MOTS-c is a mitochondrial-encoded 16-amino-acid peptide. It is a research compound, not an exercise drug.
- What do researchers study MOTS-c for?
- Researchers study MOTS-c for AMPK, insulin sensitivity and exercise-mimetic effects, mostly in animals. Treat human wellness claims as unproven.
- Is MOTS-c a medicine in Australia?
- MOTS-c is discussed here as a research compound. This site does not present it as a TGA-approved medicine or a treatment. Product links go to RegenPep, an Australian storefront that supplies research peptide pens for laboratory use.
- Which supplier does MOTS-c link to, and why?
- Profiles link to the matching MOTS-c line on RegenPep. We recommend that supplier on manufacturing quality — third-party purity and identity testing, a Certificate of Analysis per batch, documented lot and sourcing information, and lab-reported potency consistency. This reflects manufacturing and testing quality only. It is not a claim that any compound named here is safe or effective for human use, and nothing on Peptide Brief recommends human consumption. Commercial disclosure: Peptide Brief is operated by the same people as RegenPep, the store these links open. We have a financial interest in purchases made there.
Peptide Brief · updated 4 September 2026. Research and educational information only.
Not evaluated or approved by the TGA/FDA. Not intended to diagnose, treat, cure, or prevent any disease.